Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Amantadine Hydrochloride Tablets, 100mg, a generic version of Symmetrel®* Tablets, 100mg. Amantadine Hydrochloride Tablets, 100mg, are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Amantadine Hydrochloride Tablets, 100mg, are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions. For more information please contact the Company directly at info@dexcelpharmausa.com.
Amantadine Hydrochloride Tablets Approval
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.